CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced US FDA 510(k) clearance of its CARESCAPE Canvas patient monitoring platform for precise, flexible patient care. CARESCAPE Canvas ...
The new bedside monitor Carescape Canvas will work in tandem with the Carescape One acquisition device also developed by GE Healthcare Technologies Inc. and cleared for sale in the U.S. in 2019.
CARESCAPE Canvas builds on GE HealthCare’s 50+ years of clinical excellence and provides a unified patient monitoring solution that is reliable, flexible, scalable and intuitive to use ...